Role
Principal Investigator
Description
Recent ME/CFS research focuses on blood biomarkers for diagnosis, prognosis, and treatment monitoring. Immune dysregulation, mitochondrial dysfunction, and metabolic changes are highlighted as key pathways. Omics technologies aid in discovering novel biomarkers and understanding disease heterogeneity. Challenges like sample variation and reproducibility underscore the importance of collaboration and standardization. Despite obstacles, biomarker discovery offers potential for early detection, personalized treatment, and better outcomes. This research signals a move towards precision medicine in ME/CFS management, promising transformative impact in clinical practice.
Date
07 Jun 2024 - 30 Jun 2027
Project Type
CONTRACT_RESEARCH
Keywords
ME/CFS;biomarkers;transcriptomics
Funding Body
La Trobe University
Amount
43000
Project Team
Subir Sarker